Patient Travel and Reimbursements for AL Amyloidosis Study
This three-year rare disease study was being conducted at 75 study sites throughout the United States, Canada, Europe, and Australia. The study required a 13-month commitment from patients, and had a rigorous visit calendar for the first 3 months of treatment, thus the sponsor was seeking assistance with patient travel and coordination.
Please fill out the form on the right to review the case study.
ClinEdge (en-US)Accelerating Clinical Trialshttps://stage.clin-edge.comHomehttps://stage.clin-edge.comCaseshttps://stage.clin-edge.com/caseshttps://stage.clin-edge.com/cases/patient-travel-and-reimbursements-for-al-amyloidosis-study